ScienceDex / Researcher record
Kevin Loring Winthrop
- Oregon Health & Science University · Public Health (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
- Diverse Portfolio
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,807,914 | 3 | #2,964 |
| 2025 | $4,412,599 | 4 | #1,755 |
| 2026 | $976,711 | 2 | #19,918 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20243 records
- FY2025 · selected4 records
- FY20262 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9238815Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Public Health
- Internal Medicine
FY2025 award records by amount
NIH award records listing Kevin Loring Winthrop as a PI. Multi-PI records show the full award amount for context.
- 4R01AI175935-02R01Contact PIMycobacterium avium complex pulmonary infection: immunologic and transcriptomic signatures of disease and treatment responseOregon Health & Science University · Public Health (NIH department code)$2.3Maward amount
- 5U01DC020175-04U01Contact PIPhase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Ototoxicity in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium InfectionOregon Health & Science University · Public Health (NIH department code)$1.1Maward amount
- 5R01AI177986-02R01Contact PICRISPR detection of circulating cell-free Mycobacterium avium complex (MAC) DNA for rapid diagnosis and monitoring of MAC pulmonary diseaseOregon Health & Science University · Public Health (NIH department code)$742.8Kaward amount
- 1R34AI186857-01R34Co-investigatorNovel strategies for treatment of Mycobacterium abscessus pulmonary diseaseMedical University of South Carolina · Internal Medicine (NIH department code)$240.9Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Kevin Loring Winthrop as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardOregon Health & Science University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2964
- 2024Entered Top 25% NationallyRanked #2964
- 2025$5M Cumulative Funding
- 2025Entered Top 10% NationallyRanked #1755
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Kevin Loring Winthrop.